A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis

• Status: Completed
• Trial end date: 2020-05-05
• Target enrollment: 0
• Participant gender: All

Summary

The study is being done to determine and compare the safety and effectiveness of an investigational combination therapy (low and high concentrations) versus mono-therapy (low and high concentrations) or mono-therapy (fixed concentration) in subjects with moccasin type tinea pedis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Therapeutics, Inc.

Criteria

Inclusion Criteria:

• Male or non-pregnant female, 16 years of age or older.

• Clinical diagnosis of moccasin type tinea pedis

• Microscopic evidence (positive KOH) of the presence of fungi

• Provided written informed consent/assent

• In general good health

Exclusion Criteria:

• Pregnant or lactating or planning to get pregnant while on the study

• Has concurrent tinea infection (e.g., tinea versicolor, tinea cruris)

• Other skin disease which might interfere with the evaluation of tinea pedis

• History of diabetes mellitus or is immunocompromised

• Currently enrolled in an investigational drug or device study

• Used an investigational drug or investigational device treatment within 30 days prior to Visit 1 (Study Day 1)/Baseline

Other protocol defined inclusion or exclusion criteria assessed by the study staff may apply.